Jonathan Mark Hopper Vericel Corp (VCEL) insider trading activity

Jonathan Mark Hopper is Chief Medical Officer of Vericel Corp. Currently has a direct ownership of 58,229 shares of VCEL, which is worth approximately $3.36 Million. The most recent transaction as insider was on Sep 03, 2024, when has been sold 10,000 shares (Common Stock) at a price of $49.83 per share, resulting in proceeds of $498,300. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 58.2K

0.19% 3M change

9.85% 12M change

Total Value Held $3.36 Million

Jonathan Mark Hopper Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 03 2024	SELL Open market or private sale	$498,300 $49.83 p/Share	10,000 Reduced 14.66%	58,229 Common Stock
Sep 03 2024	BUY Exercise of conversion of derivative security	$109,500 $10.95 p/Share	10,000 Added 12.78%	68,229 Common Stock
May 20 2024	SELL Open market or private sale	$499,900 $49.99 p/Share	10,000 Reduced 14.68%	58,116 Common Stock
May 20 2024	BUY Exercise of conversion of derivative security	$109,500 $10.95 p/Share	10,000 Added 12.8%	68,116 Common Stock
Feb 20 2024	SELL Payment of exercise price or tax liability	$153,747 $49.5 p/Share	3,106 Reduced 5.09%	57,953 Common Stock
Feb 20 2024	BUY Exercise of conversion of derivative security	-	7,075 Added 10.76%	58,695 Common Stock
Feb 12 2024	SELL Payment of exercise price or tax liability	$36,750 $47.42 p/Share	775 Reduced 1.42%	53,984 Common Stock
Feb 12 2024	BUY Exercise of conversion of derivative security	-	1,625 Added 2.88%	54,759 Common Stock
Nov 20 2023	SELL Open market or private sale	$182,000 $36.4 p/Share	5,000 Reduced 8.62%	53,007 Common Stock
Nov 20 2023	BUY Exercise of conversion of derivative security	$54,750 $10.95 p/Share	5,000 Added 7.94%	58,007 Common Stock
Feb 19 2023	SELL Payment of exercise price or tax liability	$22,424 $29.82 p/Share	752 Reduced 1.41%	52,412 Common Stock
Feb 19 2023	BUY Exercise of conversion of derivative security	-	1,750 Added 3.19%	53,164 Common Stock
Feb 18 2023	SELL Payment of exercise price or tax liability	$33,040 $29.82 p/Share	1,108 Reduced 2.11%	51,414 Common Stock
Feb 18 2023	BUY Exercise of conversion of derivative security	-	2,325 Added 4.24%	52,522 Common Stock
Feb 11 2023	SELL Payment of exercise price or tax liability	$24,612 $29.3 p/Share	840 Reduced 1.65%	50,197 Common Stock
Feb 11 2023	BUY Exercise of conversion of derivative security	-	1,625 Added 3.09%	51,037 Common Stock
Feb 06 2023	SELL Payment of exercise price or tax liability	$9,486 $30.6 p/Share	310 Reduced 0.62%	49,412 Common Stock
Feb 06 2023	BUY Exercise of conversion of derivative security	-	650 Added 1.29%	49,722 Common Stock
Mar 01 2022	SELL Open market or private sale	$693,455 $41.43 p/Share	16,738 Reduced 25.39%	49,176 Common Stock
Mar 01 2022	BUY Exercise of conversion of derivative security	$289,600 $14.48 p/Share	20,000 Added 26.35%	55,914 Common Stock
Feb 19 2022	SELL Payment of exercise price or tax liability	$25,477 $34.9 p/Share	730 Reduced 1.57%	45,914 Common Stock
Feb 19 2022	BUY Exercise of conversion of derivative security	-	1,750 Added 3.62%	46,644 Common Stock
Feb 11 2022	SELL Payment of exercise price or tax liability	$27,326 $35.26 p/Share	775 Reduced 1.7%	44,894 Common Stock
Feb 11 2022	BUY Exercise of conversion of derivative security	-	1,625 Added 3.44%	45,669 Common Stock
Feb 06 2022	SELL Payment of exercise price or tax liability	$10,512 $33.91 p/Share	310 Reduced 0.7%	44,044 Common Stock

JMH

Jonathan Mark Hopper

Chief Medical Officer

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VCEL shares.

Notify only if

Value

Insider Trading

Get notified when an Vericel Corp insider buys or sells VCEL shares.

Notify only if

Operation

Value

Type

News

Receive news related to Vericel Corp

Track Activities on VCEL

Account